MedTrace Logo

Acute Kidney Injury - Biomarkers in Major Abdominal Surgery

NCT04582747 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2020-10-12

No results posted yet for this study

Summary

To validate Urinary Biomarkers for the prediction of AKI in major abdominal surgery patients

Conditions

Interventions

DIAGNOSTIC_TEST

Urinary Biomarkers (NGAL, DKK-3, IGFBP-7/TIMP-2, KIM-1)

Validation of Urinary biomarker tests for the rapid prediction of AKI. No intervention is being proposed as part of the study. Concentrations of Urinary biomarkers will be obtained post operatively. These concentrations will be assessed to ascertain their predictive ability for the development of Acute Kidney Injury post-operatively.

Sponsors & Collaborators

  • Royal Surrey County Hospital NHS Foundation Trust

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-03
Primary Completion
2020-03-03
Completion
2020-03-03

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04582747 on ClinicalTrials.gov